Glaxosmithkline (GSK) To Establish Its Global Asia Headquarters In Singapore to Oversee the Pharmaceuticals Businesses in Asia

Posted on 2018-08-16 by Goldstein Research in Internet & Online // 0 Comments

New York, USA, 2018-Aug-16 — /EPR Network/ —According to Goldstein Research, Singapore pharmaceutical market is segmented on the basis of products and by therapeutics. Therapeutics segment is further categorized into cardiovascular diseases, diabetes, respiratory diseases, infectious diseases, oncology diseases, central nervous system disorders (CNS) disorders, gastrointestinal, other diseases (dermatology, rheumatology). Cardiovascular and infectious diseases occupies largest share of Singapore pharmaceutical market followed by oncology and respiratory diseases. Cardiovascular diseases accounted for 25% share of Singapore pharmaceutical market in 2016, and is projected register robust growth during the forecast period. Rising prevalence of gastrointestinal problems and diabetes is expected to increase the demand for therapeutics in Singapore over the forecast period.

“Singapore Pharmaceutical Market Outlook, 2016-2024” covers the present ground scenario and future opportunity prospects for the market players to analyze the target markets across the globe. Moreover, competitive analysis includes the in-depth analysis of the major players and leaders in healthcare industry. The market study conducted on the basis of primary as well as secondary research where the analysts fragment the data from various databases such as Bloomberg, Factiva, Owler and others. Our primary research team conducted various interviews, surveys and group discussions of medical devices manufacturers, suppliers, and distributors, pharmaceutical & biotechnology companies, cosmetic product manufacturers, healthcare institutions, clinical centers, medical research laboratories and academic medical centers and universities to analyze the future prospects of the overall healthcare industry.

Request Report Sample @ https://www.goldsteinresearch.com/request-sample/singapore-pharmaceutical-market-outlook-2024-opportunity-assessment-and-demand-analysis-market-forecast-2016-2024

Singapore Pharmaceutical Market Segmentation can be classified on the basis of:

Based on Products

Over-the-counter (OTC) drugs
Generic Drugs
Patented Drugs

Based on Therapeutics

Cardiovascular Diseases
Diabetes
Respiratory Diseases
Infectious Diseases
Oncology
Gastrointestinal Problems
Central Nervous System (CNS) Disorders
Other Diseases (Dermatology, Rheumatology)

Market Trends, Drivers and Challenges

Increasing number of Singapore’s multinational corporations and local startups to manufacturer and export medical equipments across the world is the ongoing trend. Several medical products are exported from Singapore such as syringes, catheters, research instruments and scientific analytical equipments.Singapore’s advanced infrastructure, political stability, strong intellectual property law and acceptability towards advance technology offers plentiful advantages to pharmaceutical industry of the country. Singapore pharmaceutical industries are adopting robotic based technology for physical therapy and surgeries which is gaining immense popularity across the world.Despite of being the largest potential market for pharmaceutical industry, foreign drug manufacturers faces problems while exporting in Singapore. Product license from Association of Southeast Asian Nations (ASEAN) or ASEAN Common Technical Dossier (ACTD) to export and import of drugs in Singapore market is mandatory for all foreign drug companies. Foreign drug companies producing innovative drugs are facing challenges in exporting products in Singapore market.

“Singapore Pharmaceutical Market Report” has been prepared based on an in-depth market analysis from industry experts. The report covers the competitive landscape and current position of major players in the market space. The report also includes porter’s five force model, SWOT analysis, company profiling, business strategies of market players and their business models. Singapore Pharmaceutical MarketReport also recognizes value chain analysis to understand the cost differentiation to provide competitive advantage to the existing and new entry players.

Browse Full Report: https://www.goldsteinresearch.com/report/singapore-pharmaceutical-market-outlook-2024-opportunity-assessment-and-demand-analysis-market-forecast-2016-2024

About Goldstein Research

Based in the US, Goldstein Research currently has a strong presence in the American and Asian countries. In the next five years, we strive to expand our reach to 50+ nations spanning across Europe, Asia and parts of the Middle East and Africa. We strive to realize a strong brand presence globally through our quality research and forecasting solutions.

Our mission is simple: to develop insightful business solutions, help our clients make powerful future decisions to keep them well ahead of the game which is the market, and leave a mark across businesses and communities through our well-defined ideas and clear-cut forecasts. Our market research reports provide in-depth analysis of global and regional variations along with competitors’ overview.

Our analysts working on healthcare market research reports to help various tech-giants, tech start-ups and entry players to assess the current and upcoming business scenario. We believe in the vigorous examination of the current market scenario and build around creative ideas and approaches that are most suitable to our clients’ needs and business agenda.

Based on Products

Based on Therapeutics

About Goldstein Research

Matched content

Editor’s pick